DARZALEX

Concentrate for solution for infusion, 20mg/ml
RxActive license

Active substance (INN)

daratumumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength20mg/ml
PackagingUkupno 1 bočica staklena sa 20ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerJanssen Biologics B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L01FC01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 3, 2025

Analogs in Montenegro

2

Other medicines with the same active substance

DARZALEXRx
Solution for injection, 1800mgJanssen Biologics B.V.
DARZALEXRx
Concentrate for solution for infusion, 20mg/mlJanssen Biologics B.V.
Source: CInMED register